Neurocognitive Decline

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-09
Clinical Trial Update: MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling
Clinical trial update for the MISTIC study on subclinical atherosclerotic cardiovascular disease and neurocognitive decline; the study is no…